Respiratory diseases in the era of Covid‑19: Pearls and pitfalls

Bolaki,Maria; Tsitoura,Eliza; Spandidos,Demetrios A.; Symvoulakis,Emmanouil K.; Antoniou,Katerina M.

doi:10.3892/etm.2020.8776

Respiratory diseases in the era of Covid‑19: Pearls and pitfalls

Authors:
- Maria Bolaki
- Eliza Tsitoura
- Demetrios A. Spandidos
- Emmanouil K. Symvoulakis
- Katerina M. Antoniou
View Affiliations

Affiliations: Department of Respiratory Medicine, Laboratory of Molecular and Clinical Pneumonology, Faculty of Medicine, University of Crete, 71003 Heraklion, Greece, Laboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Greece, Clinic of Social and Family Medicine, Faculty of Medicine, University of Crete, 71003 Heraklion, Greece
Published online on: May 20, 2020 https://doi.org/10.3892/etm.2020.8776
Pages: 691-693
Copyright: © Bolaki et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Coronavirus disease 2019, a respiratory tract infection that has evolved into a pandemic, is expected to affect patients with underlying respiratory disease in a greater number and greater severity than patients with other underlying disorders. Whether this is true is an interesting question. However, the challenge both for the doctors and patients is to keep the respiratory disease in remission and prevent any exacerbations. Proper recommendations have been proposed for a wide range of respiratory disorders including chronic obstructive pulmonary disease (COPD), asthma and interstitial lung diseases, regarding the continuation or not of the treatment during this period and ways to maintain stability.

View Figures

View References

1	Halpin DMG, Faner R, Sibila O, Badia JR and Agusti A: Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 8:436–438. 2020.PubMed/NCBI View Article : Google Scholar
2	World Health Organization (WHO): Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). WHO, Geneva, 2020. https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19). Accessed February 28, 2020.
3	Jain V and Yuan JM: Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection. medRxiv: doi: https://doi.org/10.1101/2020.03.15.20035360.
4	Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N, Deng Y and Lin S: The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis. J Med Virol: April 15, 2020 (Epub ahead of print).
5	National Institute for Health and Care Excellence (NICE): COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD). NICE guideline [NG168). http://www.nice.org.uk/guidance/ng168https://www.nice.org.uk/guidance/ng168. Accessed April 9, 2020.
6	Halpin DMG, Singh D and Hadfield RM: Inhaled corticosteroids and COVID-19: A systematic review and clinical perspective. Eur Respir J. 55(2001009)2020.PubMed/NCBI View Article : Google Scholar
7	National Institute for Health and Care Excellence (NICE): COVID-19 rapid guideline: severe asthma. NICE guideline [NG166). http://www.nice.org.uk/guidance/ng166https://www.nice.org.uk/guidance/ng166. Accessed April 3, 2020.
8	The Lancet Respiratory Medicine. Reflecting on World Asthma Day in the era of COVID-19. Lancet Respir Med. 8(423)2020.PubMed/NCBI View Article : Google Scholar
9	British Thoracic Society: British Thoracic Society Advice for Managing Interstitial Lung Disease Patients during COVID-19 pandemic. https://brit-thoracic.org.uk/media/455101/bts-management-advice-for-ild-patients-v10-23-march-2020.pdf. Accessed March 23, 2020.
10	Lee JYT, Tikellis G, Corte TJ, Goh NS, Keir GJ, Spencer L, Sandford D, Khor YH, Glaspole I, Price J, et al: The supportive care needs of people living with pulmonary fibrosis and their caregivers: A systematic review. Eur Respir Rev. 29(190125)2020.PubMed/NCBI View Article : Google Scholar
11	The LAM Foundation: The LAM Foundation COVID-19 Statement. https://thelamfoundation.org/Portals/0/Files/Documents/COVID-19%20Statement%2003.18.20.pdf. Accessed March 18, 2020.
12	Ceribelli A, Motta F, De Santis M, Ansari AA, Ridgway WM, Gershwin ME and Selmi C: Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy. J Autoimmun. 109(102442)2020.PubMed/NCBI View Article : Google Scholar
13	Matucci-Cerinic M, Bruni C, Allanore Y, Clementi M, Dagna L, Damjanov NS, de Paulis A, Denton CP, Distler O, Fox D, et al: Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management. Ann Rheum Dis: April 29, 2020 (Epub ahead of print).
14	Mihai C, Dobrota R, Schröder M, Garaiman A, Jordan S, Becker MO, Maurer B and Distler O: COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD. Ann Rheum Dis. 79:668–669. 2020.PubMed/NCBI View Article : Google Scholar
15	Colombo C, Burgel PR, Gartner S, van Koningsbruggen-Rietschel S, Naehrlich L, Sermet-Gaudelus I and Southern KW: Impact of COVID-19 on people with cystic fibrosis. Lancet Respir Med. 8:e35–e36. 2020.PubMed/NCBI View Article : Google Scholar
16	National Institute for Health and Care Excellence (NICE): COVID-19 rapid guideline: cystic fibrosis. NICE guideline [NG170). http://www.nice.org.uk/guidance/ng170https://www.nice.org.uk/guidance/ng170. Accessed April 9, 2020.
17	Calabrò L, Peters S, Soria JC, Di Giacomo AM, Barlesi F, Covre A, Altomonte M, Vegni V, Gridelli C, Reck M, et al: Challenges in lung cancer therapy during the COVID-19 pandemic. Lancet Respir Med: Apr 9, 2020 (Epub ahead of print).
18	National Institute for Health and Care Excellence (NICE): COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community. NICE guideline [NG165). http://www.nice.org.uk/guidance/ng165https://www.nice.org.uk/guidance/ng165. Accessed April 3, 2020.
19	Skalny AV, Rink L, Ajsuvakova OP, Aschner M, Gritsenko VA, Alekseenko SI, Svistunov AA, Petrakis D, Spandidos DA, Aaseth J, et al: Zinc and respiratory tract infections: Perspectives for COVID 19 (Review). Int J Mol Med. 46:17–26. 2020.PubMed/NCBI View Article : Google Scholar
20	Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, Shrestha BR, Arabi YM, Ng J, Gomersall CD, et al: Asian Critical Care Clinical Trials Group: Intensive care management of coronavirus disease 2019 (COVID-19): Challenges and recommendations. Lancet Respir Med. 8:506–517. 2020.PubMed/NCBI View Article : Google Scholar